Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

This patient's cancer was considered uncurable—until he got a genetic sequencing test.

While it could take months – or even years – to fully assess the damage of the Los Angeles wildfires, the need for assistance ...

Kimberly Feigin, MD, has been named Chief of the Breast Imaging Service within the Department of Radiology. Dr. Feigin has ...

Join this free webcast to find out how to lead the charge in crafting benefits packages that address a wide range of issues related to musculoskeletal conditions.

The following is a summary of “Evaluating Digital Rehabilitation Outcomes in Chronic Musculoskeletal Conditions Across Non-Obesity, Obesity, and Severe Obesity,” published in the January 2025 issue of ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

Pillar Biosciences, Inc. has entered into a strategic five-year licensing agreement with Memorial Sloan Kettering Cancer ...

Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a ...

MSK Doctors (03300010048), a London-based private practice that specialises in treatments for musculoskeletal disorders, has released a new ...